Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Daiichi Sankyo
Accenture
Federal Trade Commission
Moodys
McKinsey
McKesson
Julphar

Generated: June 17, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: zanamivir

« Back to Dashboard

zanamivir

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Glaxosmithkline RELENZA zanamivir POWDER;INHALATION 021036 NDA GlaxoSmithKline LLC N 0173-0681-01
Glaxosmithkline RELENZA zanamivir POWDER;INHALATION 021036 NDA Physicians Total Care, Inc. E 54868-4377-0
Glaxosmithkline RELENZA zanamivir POWDER;INHALATION 021036 NDA Dispensing Solutions Inc. E 68258-3030-1
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Queensland Health
US Department of Justice
Baxter
McKinsey
Johnson and Johnson
Citi
Fuji
McKesson